Coastal Bridge Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-5,838
Closed -$268K – 164
2022
Q1
$268K Sell
5,838
-442
-7% -$21.1K 0.06% 125
2021
Q4
$385K Hold
6,280
– – 0.08% 121
2021
Q3
$469K Sell
6,280
-109
-2% -$9.14K 0.11% 86
2021
Q2
$591K Buy
6,389
+92
+1% +$7.82K 0.12% 81
2021
Q1
$559K Buy
+6,297
New +$625K 0.1% 78

Other funds holding ARKG

Coastal Bridge Advisors's ARKG Position: Q2 2022 in Review

Coastal Bridge Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 5,838 shares — an estimated $268K sold.

Coastal Bridge Advisors first reported a position in ARKG in Q1 2021 and held it in 5 quarters. The position peaked at $591K in Q2 2021. 334 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

  • Coastal Bridge Advisors reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
  • Coastal Bridge Advisors sold 5,838 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $268K.
  • Coastal Bridge Advisors first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 5 quarters.
  • Coastal Bridge Advisors's ARK Genomic Revolution ETF position peaked at $591K in Q2 2021.
  • 334 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on Coastal Bridge Advisors's 13F filing for Q2 2022, filed 5 Aug 2022.